OmniCAR is next generation CAR-T. The only platform that can deliver mass commercialisation with scale, safety and affordability.
3 CAR-T programs in addition to PTX100 and PTX200 which are relatively advanced and are progressing, both are potential company makers.
Now we know why well respected haematologist and blood cancer specialist Professor Miles Prince joined the PTX advisory board in addition to one of the primary pioneers of CAR-T joining the board, Dr Allen Ebens.
Reminder why the OmniCAR platform is a game changer for CAR-T therapy.
